Prime named 2021 Minnesota Women Lawyers Leadership Award recipient

Support for women in the workplace celebrated

April 30, 2021
Minnesota Women Lawyers (MWL) presented Prime Therapeutics with the MWL Leadership Award at its recent 49th Annual Meeting. This annual award recognizes a Minnesota legal employer that strives to enhance the status, influence and effectiveness of women lawyers.

Prime is committed to advancing the success of women in the legal department in a variety of ways:

  • Prime’s legal leadership team of five includes three women, all of whom have been promoted multiple times during their employment with Prime, and two of whom are company officers and members of Prime’s senior leadership team
  • Three of the nine lawyers in the legal department are women and nine of the 18 employees in the department are women
  • Effective Jan. 1, 2021, Prime’s legal department implemented a policy intended to hold its law firm vendors directly accountable to Prime for their efforts toward driving greater diversity, equity and inclusion among the attorneys who represent Prime

The MWL Leadership Award recognition is an extension of Prime’s overall commitment to women throughout its organization. Prime recruits and hires women at all levels of the company and participated in outreach efforts that increased female candidates by nearly 20% from 2019 to 2020.

“The legal profession is the nation’s least diverse profession, so developing and supporting women lawyers as leaders, both within Prime and the legal profession, is work that legal employers must continue to focus on,” says Amy Taber, AVP, assistant general counsel. “I’m grateful to work for a company that is recognized for its leadership in supporting women lawyers and to have Mike Kolar as a General Counsel who is committed to this work.”

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion